Emerging multiple sclerosis disease-modifying therapies.

Autor: Giacomini PS, Darlington PJ, Bar-Or A, Giacomini, Paul S, Darlington, Peter J, Bar-Or, Amit

Publikováno v: Current Opinion in Neurology; 2009 Jun, Vol. 22 Issue 3, p226-232, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.

Autor: Oh J; Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada., Bhan V; University of British Columbia, Vancouver, British Columbia, Canada., Traboulsee A; Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada., Morrow SA; University of Calgary, Hotchkiss Brain Institute, Calgary, Alberta, Canada., Lee L; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Levin M; Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Casserly C; London Health Sciences Centre, London, Ontario, Canada., Freedman MS; University of Ottawa Department of Medicine, and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Giacomini PS; Montreal Neurological Institute and Hospital, Montreal, Québec, Canada., Émond F; CHU de Québec (Université Laval) & CIUSSS Capitale-Nationale - IRDPQ, Quebec City, Québec, Canada., Smyth P; Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada., Clift F; Memorial University, St. John's, Newfoundland and Labrador, Canada., Selchen D; Barlo MS Centre, Division of Neurology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.

Publikováno v: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2024 May 23, pp. 1-4. Date of Electronic Publication: 2024 May 23.

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Autor: Cross AH; Washington University School of Medicine, St Louis, Missouri., Gelfand JM; University of California, San Francisco., Thebault S; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Bennett JL; University of Colorado Anschutz Medical Campus, Aurora., von Büdingen HC; F. Hoffmann-La Roche, Basel, Switzerland., Cameron B; Genentech, South San Francisco, California., Carruthers R; University of British Columbia, Vancouver, British Columbia, Canada., Edwards K; MS Center of Northeastern New York, Latham., Fallis R; The Ohio State University Wexner Medical Center, Columbus., Gerstein R; University of Massachusetts Medical School, Worcester., Giacomini PS; McGill University, Montreal, Quebec, Canada., Greenberg B; The University of Texas Southwestern Medical Center, Dallas., Hafler DA; Yale School of Medicine, New Haven, Connecticut., Ionete C; University of Massachusetts Medical School, Worcester., Kaunzner UW; Weill Cornell Medicine, New York, New York., Kodama L; Genentech, South San Francisco, California., Lock C; Stanford University, Stanford, California., Longbrake EE; Yale School of Medicine, New Haven, Connecticut., Musch B; Genentech, South San Francisco, California., Pardo G; Oklahoma Medical Research Foundation, Oklahoma City., Piehl F; Karolinska Institutet, Solna, Sweden., Weber MS; Institute of Neuropathology, Department of Neurology, University Medical Center, Göttingen, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany., Yuen S; Genentech, South San Francisco, California., Ziemssen T; Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Dresden, Germany., Bose G; Department of Medicine in Neurology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Freedman MS; Department of Medicine in Neurology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Anania VG; Genentech, South San Francisco, California., Ramesh A; Genentech, South San Francisco, California., Winger RC; Genentech, South San Francisco, California., Jia X; Genentech, South San Francisco, California., Herman A; Genentech, South San Francisco, California., Harp C; Genentech, South San Francisco, California., Bar-Or A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Publikováno v: JAMA neurology [JAMA Neurol] 2024 Mar 11. Date of Electronic Publication: 2024 Mar 11.